China SXT Pharmaceuticals Inc

China SXT Pharmaceuticals Inc (SXTC) Stock Analysis

$2.220

-0.217 (-9.76%)At close

Loading chart…
High
2.500
Open
2.500
VWAP
2.26
Vol
106.51K
Mkt Cap
1.01M
Low
2.060
Amount
240.71K
EV/EBITDA, TTM
0.00

China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang.

www.sxtchina.com

AI analysis of China SXT Pharmaceuticals Inc (SXTC)

sell

Given the current price of $3.00 and an RSI of 23.016, which indicates that the stock is oversold, SXTC does not present a good buying opportunity right now. The stock has experienced a staggering 99.99% decline year-to-date, reflecting severe underlying issues. Additionally, the recent reverse stock split and subsequent price drop of nearly 30% raise significant concerns about the company's stability and future prospects.

Valuation Metrics

The current forward P/E ratio for China SXT Pharmaceuticals Inc (SXTC) is 0.00, compared to its 5-year average forward P/E of 0.00.

Forward P/E

Strongly Undervalued
5Y Average P/E
0.00
Current P/E
0.00
Overvalued
0.00
Undervalued
0.00

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued
0.00
Undervalued
0.00

Forward P/S

Strongly Undervalued
5Y Average P/S
0.00
Current P/S
0.00
Overvalued
0.00
Undervalued
0.00

Alphio AI Price Scenarios for SXTC

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%SXTC

$2.24

Scenario price

B

Base

Base · 50%SXTC

$1.99

Scenario price

B

Bear

Bear · 25%SXTC

$1.73

Scenario price

Events Timeline

2026-07-23 (ET)

09:30:00

China SXT Pharmaceuticals Issues 4.5M Units at $2.00 Each

2026-07-07 (ET)

17:00:00

Company Not Selling 157.5M Class A Ordinary Shares

2026-01-15 (ET)

09:20:00

China SXT Pharmaceuticals Launches AI Initiative to Enhance TCM Supply Chain

2026-01-09 (ET)

15:00:00

China SXT Pharmaceuticals Enters Agreement to Sell 66.67M Shares

2026-01-08 (ET)

16:30:00

Major Averages Mixed as Oil Prices Surge Nearly 4%

Show More Events

News

Show More News

SXTC FAQ — answered by Alphio AI

China SXT Pharmaceuticals Inc is a holding company mainly engaged in the research, development, manufacture, marketing and sales of Chinese traditional medicine products (TCMP). The Company sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The Company sells its products under the brand Suxuantang. It operates in the Healthcare sector (PHARMACEUTICAL PREPARATIONS industry).

Given the current price of $3.00 and an RSI of 23.016, which indicates that the stock is oversold, SXTC does not present a good buying opportunity right now. The stock has experienced a staggering 99.99% decline year-to-date, reflecting severe underlying issues. Additionally, the recent reverse stock split and subsequent price drop of nearly 30% raise significant concerns about the company's stability and future prospects.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started